Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1359-1365

  Freund, Christian T F ^a   Sutton, Mark A ^a   Dang, Truong ^a   Contant, Charles F ^a   Rowley, David ^a   Lerner, Seth P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; Cytokines; Gene therapy; IL 2

Indexed keywords

INTERLEUKIN 2;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HERPES SIMPLEX; INTERLEUKIN-2; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; THYMIDINE KINASE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0033854865     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sutton MA, Berkman SA, Chen S-H, Block A, Dang TD, Kattan MW, Wheeler TM, Rowley DR, Woo SLC and Lerner SP: Adenovirus-mediated suicide gene therapy for experimental bladder cancer. Urology 49: 173-180, 1997.
2. Landis SH, Murray T, Bolden S and Wingo PA: Cancer Statistics 1999. CA Cancer J Clin 49: 8-31, 1999.
3. Descamps V, Duffour M-T, Mathieu M-C, Fernandez N, Cordier L, Ahina MA, Kremer E, Perricaudet M and Haddada H: Strategies for cancer gene therapy using adenoviral vectors. J Mol Med 74: 183-189, 1996.
4. Vile RG, Diaz RM, Castleden S and Chong H: Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumor immunity that can be augmented by coexpression of cytokines in the tumor cells. Biochemical Society Transactions 25: 717-722, 1996.
5. Deonarain MP, Spooner RA and Epenetos AA: Genetic delivery of enzymes for cancer therapy. Gene Ther 2: 235-244, 1995.
6. Elshami AA, Saavedra A, Zhang H, Kucharczuk JC, Spray DC, Fishman GI, Amin KM, Kaiser LR and Albelda SM: Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 3: 85-92, 1996.
7. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL and Abraham GN: The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283, 1993.
8. Wygoda MC, Wilson MR, Davis MA, Trosko JE, Rehemtulla A and Lawrence TS: Protection of herpex simplex virus thymidine kinasetransduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the good Samaritan effect. Cancer Research 57: 1699-1703, 1997.
9. Dilber MS and Smith CIE: Suicide genes and bystander killing: local and distant effects. Gene Ther 4: 273-274, 1997.
10. Vile RG, Castleden S, Marshall J, Camplejohn R, Upton C and Chong H: Generation of an anti-tumor immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. International Journal of Cancer 71: 267-274, 1997.
11. Ramesh R, Marrogi AJ, Munshi A, Abboud CN and Freeman SM: In vivo analysis of the 'bystander effect': a cytokine cascade. Exp Hematol 24: 829-838, 1996.
12. Freeman SM, Ramesh R, Marrogi AJ: Immune system in suicidegene therapy. Lancet 349: 2-3, 1997.
13. Vogelzang NJ, Scardino PT, Shipley WU and Coffey DS: Bladder cancer. In: Comprehensive textbook of genitourinary oncology eds. (ed 1). Baltimore, Williams & Wilkins, 1996, pp.427-433.
14. Ratliff TL: Bacillus calmette-guerin: mechanism of action in superficial bladder cancer. Urology (supplement) 37: 8-11, 1991.
15. Atzpodien J, Schomburg A and Buer J: Interleukin-2. In: Immunotherapy in Cancer (Gore M, Riches P, eds). New York, Wiley & Sons, 1996, pp. 43-75.
16. Sargent ER and Williams RD: Immunotherapeutic alternatives in superficial bladder cancer. Urol Clin North Am 19: 581-589, 1992.
17. Cordier L, Duffour M-T, Sabourin J-C, Lee MG, Cabannes J, Ragot T, Perricaudet M and Haddada H: Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther 2: 16-21, 1995.
18. Addison CL, Braciak T, Ralston R, Muller WJ, Gauldie J and Graham FL: Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc Natl Acad Sci USA 92: 8522-8526, 1995.
19. Fox BA and Nabel GJ: The potential of gene transfer to alter the immune response to tumors. In: Tumor immunology (Dalgleish AG, Browning MJ, eds). Cambridge, Cambridge University Press, pp 300-326, 1996.
20. Zier KS and Gansbacher B: IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells. Journal of Molecular Medicine 74: 127-134, 1996.
21. Soloway MS, Niell HB, Matheny RB and Blatnik A: Systemic chemotherapy of murine bladder cancer. Urology 13: 129-134, 1984.
22. Chen SH, Shine HD, Goodman JC, Grossman RG and Woo SL: Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91: 3054-3057, 1994.
23. Graham FL and Prevec L: Manipulation of adenovirus vectors. In: Methods in molecular biology: gene transfer and expression protocols. (Murray EJ, eds). Clifton, NY, The Humana Press Inc., pp 109-128, 1991.
24. Scudiero DA, Shoemakere RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D and Boyd MR: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other cell lines. Cancer Res 48: 4827-4833, 1988.
25. Bass C, Cabrera G, Elgavish A, Robert B, Siegal GP, Anderson SC, Maneval DC and Curiel DT: Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo. Cancer Gene Ther 2: 97-104, 1995.
26. Yang Y, Su O and Wilson JM: Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. Journal of virology 70: 7209-7212, 1996.
27. Kochanek S, Clemens PR, Mitani K, Chen H-H, Chan S and Caskey CT: A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and b-galactosidase. Proc Natl Acad Sci USA 93: 5731-5736, 1996.
28. Vile RG, Chong H and Dorudi S: The immunosurveillance of cancer, specific and nonspecific mechanisms. In: Tumor immunology (Browning AGDaMJ, eds). Cambridge, Camgridge University Press, pp 7-38, 1996.
29. Forni G and Foa R: The role of cytokines in tumor rejection. In: Tumor immunology (Dalgleish AG, Browning MJ, eds). Cambridge, Cambridge University Press, pp 199-218, 1996.
30. Saito S, Bannerij R, Gansbacher B, Rosenthal FM, Romanenko P, Heston WDW, Fair WR and Gilboa E: Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res 54: 3516-3520, 1994.
31. Connor J, Bannerij R, Saito S, Heston W, Fair W and Gilboa E: Regression of bladder tumors in mice treated with interleukin 2 genemodified tumor cells. J Exp Med 177: 1127-1134, 1993.
32. Chen S-H, Li Chen XH, Wang Y, Kosai K-I, Finegold MJ, Rich SS, and Woo SLC: Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 92: 2577-2581, 1995.
33. O'Malley Jr. BW, Sewell DA, Li D, Kosai K-i, Chen S-H, Woo SLC, Duan L: The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. Mol Endocrinol 11: 667-673, 1997.
34. Mickey DD, Mickey GH, Murphy WM, Niell HB and Soloway MS: In vitro characterization of four N-[-4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors. J Urol 127: 1233-1237, 1982.
35. Kremer EJ and Perricaudet M: Adenovirus and adeno-associated virus mediated gene transfer. Br Med Bull 51: 31-44, 1995.
36. Chen S-H, Kosai K-I, Xu B, Pham-Nguyen K, Contant C, Finegold MJ and Woo SLC: Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 56: 3758-3762, 1996.
37. Tepper RI and Mule JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Human Gene Ther 5: 153-164, 1994.